XLO
#4276
Xilio Therapeutics, Inc. - Common Stock
9.0 1 USD
0.00%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-0.22%
Monthly Change
+6.00%
6 month change
+1286.15%
Year Change
+1134.25%
Previous Close
9.0 3
Open
9.0 1
Low
9.0 0
High
9.1 1
Volume
37
Financials
- Market Capitalization 52.1 M
- Employee 76
- Founded 2016
- CEO N/A
- Website www.xiliotx.com
- Headquarter Delaware, United States
- FIGI BBG00M4D4X92
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-3.69
Price to sales ratio
3.09
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4251 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.34 USD | -0.61% | +5.59% | -9.71% | +3.09% | 56.49 M USD | ||
| 4265 |  BYSI BeyondSpring, Inc. - Ordinary Shares | 1.30 USD | -2.26% | -20.25% | -19.25% | -42.73% | 53.46 M USD | ||
| 4277 |  TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.11 USD | +0.96% | +3.94% | -5.38% | -20.95% | 51.53 M USD | ||
| 4278 |  TIL Instil Bio, Inc. - Common Stock | 7.68 USD | -1.79% | -1.41% | -2.41% | -60.60% | 52.09 M USD |
Frequently asked questions about Xilio Therapeutics, Inc. - Common Stock
What is the Xilio Therapeutics, Inc. - Common Stock stock price today?
The current price of Xilio Therapeutics, Inc. - Common Stock (XLO) is 9.01. Over the past 24 hours, the stock has changed by -0.22%. Follow the XLO chart for real-time price dynamics.
What is the stock ticker of Xilio Therapeutics, Inc. - Common Stock?
Xilio Therapeutics, Inc. - Common Stock trades under the ticker XLO. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Xilio Therapeutics, Inc. - Common Stock stock going up?
XLO has changed by -2.28% over the last week, +6.00% over the last month, and +1134.25% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Xilio Therapeutics, Inc. - Common Stock net income for the last quarter?
Xilio Therapeutics, Inc. - Common Stock reported net income of -9.53 M for the last quarter. The previous quarter showed 10.36 M, which means net income changed by -191.98%.
How many employees does Xilio Therapeutics, Inc. - Common Stock have?
As of the latest available data, Xilio Therapeutics, Inc. - Common Stock has 76 employees. Workforce size can provide additional context about the company's scale and operations.
What is Xilio Therapeutics, Inc. - Common Stock EBITDA?
Xilio Therapeutics, Inc. - Common Stock EBITDA is -13.77 M, and its EBITDA margin is -108.86%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Xilio Therapeutics, Inc. - Common Stock stock?
You can buy Xilio Therapeutics, Inc. - Common Stock (XLO) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Xilio Therapeutics, Inc. - Common Stock stock?
Investing in Xilio Therapeutics, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the XLO chart and related analysis on metatrader.com as part of your research.